X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3936) 3936
Publication (400) 400
Newsletter (72) 72
Book Review (70) 70
Magazine Article (22) 22
Newspaper Article (16) 16
Book Chapter (9) 9
Trade Publication Article (6) 6
Dissertation (4) 4
Transcript (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2813) 2813
azithromycin (2799) 2799
index medicus (1815) 1815
female (1708) 1708
male (1705) 1705
azithromycin - administration & dosage (1194) 1194
anti-bacterial agents - therapeutic use (1170) 1170
anti-bacterial agents - administration & dosage (1168) 1168
adult (1079) 1079
azithromycin - therapeutic use (1058) 1058
antibiotics (834) 834
infectious diseases (826) 826
middle aged (775) 775
pharmacology & pharmacy (748) 748
treatment outcome (717) 717
microbiology (594) 594
adolescent (560) 560
dosage and administration (553) 553
child (536) 536
animals (529) 529
drug therapy (505) 505
aged (504) 504
research (478) 478
clarithromycin (477) 477
infections (468) 468
administration, oral (450) 450
child, preschool (430) 430
erythromycin (416) 416
children (414) 414
immunology (400) 400
anti-bacterial agents - adverse effects (396) 396
drug administration schedule (393) 393
care and treatment (392) 392
anti-bacterial agents - pharmacology (389) 389
infection (388) 388
health aspects (364) 364
azithromycin - adverse effects (353) 353
infant (352) 352
azithromycin - pharmacology (336) 336
pharmacokinetics (334) 334
macrolides (330) 330
risk factors (326) 326
medicine, general & internal (324) 324
therapy (313) 313
analysis (297) 297
drug therapy, combination (288) 288
anti-bacterial agents - pharmacokinetics (281) 281
microbial sensitivity tests (272) 272
young adult (269) 269
respiratory system (261) 261
prevention (259) 259
prevalence (246) 246
abridged index medicus (241) 241
azithromycin - pharmacokinetics (241) 241
trachoma (235) 235
pediatrics (234) 234
research article (234) 234
time factors (232) 232
efficacy (230) 230
double-blind method (227) 227
medicine (217) 217
clinical trials (214) 214
drug resistance (214) 214
follow-up studies (212) 212
diagnosis (210) 210
pneumonia (209) 209
prospective studies (208) 208
antimicrobial agents (206) 206
inflammation (206) 206
resistance (204) 204
dose-response relationship, drug (201) 201
mortality (201) 201
bacteria (198) 198
disease (197) 197
ophthalmology (192) 192
macrolide antibiotics (191) 191
double-blind (190) 190
drug resistance, bacterial (190) 190
cystic fibrosis (181) 181
mice (181) 181
studies (181) 181
retrospective studies (179) 179
trachoma - drug therapy (174) 174
pregnancy (168) 168
aged, 80 and over (166) 166
complications and side effects (166) 166
usage (166) 166
epidemiology (165) 165
ciprofloxacin (164) 164
macrolide (162) 162
chlamydia infections - drug therapy (156) 156
tropical medicine (156) 156
drugs (155) 155
doxycycline (154) 154
internal medicine (151) 151
chlamydia trachomatis (150) 150
public health (144) 144
patients (143) 143
management (142) 142
clarithromycin - therapeutic use (141) 141
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3860) 3860
Japanese (47) 47
German (43) 43
French (38) 38
Russian (24) 24
Spanish (22) 22
Chinese (12) 12
Italian (5) 5
Polish (5) 5
Croatian (4) 4
Danish (4) 4
Norwegian (4) 4
Portuguese (4) 4
Korean (3) 3
Turkish (3) 3
Bulgarian (2) 2
Bosnian (1) 1
Hungarian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 11/2015, Volume 314, Issue 19, pp. 2034 - 2044
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2015, Volume 191, Issue 1, pp. 96 - 103
Rationale: Although intermittent, three-times-weekly therapy is recommended for the initial treatment of noncavitary nodular bronchiectatic Mycobacterium avium... 
Ethambutol | Mycobacterium avium complex | Treatment | Macrolides | Nontuberculous mycobacteria | treatment | EFFICACY | NONTUBERCULOUS MYCOBACTERIA | TREATMENT REGIMENS | PREVALENCE | AZITHROMYCIN | INTRACELLULARE | HIV-NEGATIVE PATIENTS | riontuberculous mycobacteria | macrolides | RESPIRATORY SYSTEM | ethambutol | INCLUDING CLARITHROMYCIN | PULMONARY-DISEASE | CLINICAL-SIGNIFICANCE | CRITICAL CARE MEDICINE | Sputum - microbiology | Antitubercular Agents - adverse effects | Humans | Middle Aged | Male | Azithromycin - administration & dosage | Anti-Bacterial Agents - therapeutic use | Ethambutol - adverse effects | Rifampin - adverse effects | Clarithromycin - administration & dosage | Female | Rifampin - therapeutic use | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Rifampin - administration & dosage | Drug Therapy, Combination | Ethambutol - therapeutic use | Republic of Korea | Antitubercular Agents - therapeutic use | Macrolides - administration & dosage | Drug Administration Schedule | Clarithromycin - adverse effects | Comorbidity | Logistic Models | Clarithromycin - therapeutic use | Macrolides - adverse effects | Mycobacterium avium Complex - drug effects | Outcome and Process Assessment (Health Care) | Mycobacterium avium-intracellulare Infection - drug therapy | Azithromycin - therapeutic use | Antitubercular Agents - administration & dosage | Aged | Ethambutol - administration & dosage | Macrolides - therapeutic use | Anti-Bacterial Agents - administration & dosage | Practice Guidelines as Topic
Journal Article
Journal Article
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 2015, Volume 9, Issue 2, p. e0003555
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0197976
Journal Article
Chest, ISSN 0012-3692, 2014, Volume 146, Issue 2, pp. 276 - 282
Journal Article
Drug Safety, ISSN 0114-5916, 9/2017, Volume 40, Issue 9, pp. 835 - 840
Digoxin is commonly prescribed to elderly patients with heart failure and atrial fibrillation, and macrolide antibiotics markedly increase the risk of digoxin... 
Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | CLARITHROMYCIN | MANAGEMENT | HEART-FAILURE | GUIDELINES | CARDIAC-ARRHYTHMIA | AZITHROMYCIN | ATRIAL-FIBRILLATION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | INHIBITION | INCREASED MORTALITY | PHARMACOLOGY & PHARMACY | UPDATE | TOXICOLOGY | Digoxin - adverse effects | Cefuroxime - adverse effects | Humans | Male | Azithromycin - administration & dosage | Case-Control Studies | Drug Interactions | Aged, 80 and over | Clarithromycin - administration & dosage | Female | Anti-Bacterial Agents - adverse effects | Cefuroxime - administration & dosage | Death, Sudden - epidemiology | Macrolides - administration & dosage | Atrial Fibrillation - drug therapy | Clarithromycin - adverse effects | Risk Factors | Erythromycin - administration & dosage | Heart Failure - drug therapy | Azithromycin - adverse effects | Erythromycin - adverse effects | Macrolides - adverse effects | Cardiotonic Agents - administration & dosage | Digoxin - administration & dosage | Aged | Anti-Bacterial Agents - administration & dosage | Ontario | Macrolide antibiotics | Usage | Dosage and administration | Sudden death | Risk factors | Heart | Cardiac arrhythmia | Clarithromycin | Digoxin | Toxicity | Azithromycin | Risk | Population studies | Confidence intervals | Cefuroxime | Fibrillation | Safety engineering | Older people | Population | Heart diseases | Heart failure | Statistical analysis | Mortality | Erythromycin | Patients | Studies | Prescription drugs | Antibiotics | Death | Health risk assessment | Geriatrics
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2008, Volume 122, Issue 6, pp. 1138 - 1144.e4
Journal Article